These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4334084)

  • 41. A phase 2 study of intermittent high-dose cyclophosphamide therapy of advanced gastrointestinal cancer.
    Schutt AJ; Hahn RG; Reitemeier RJ; Moertel CG
    Cancer Res; 1973 Oct; 33(10):2218-20. PubMed ID: 4741927
    [No Abstract]   [Full Text] [Related]  

  • 42. [Preliminary results of clinical trial of the antineoplastic antibiotic bruneomycin].
    Garim AM; Lorie IuI; Reĭzinger MA; Shkarenkov VA; Durnov LA
    Antibiotiki; 1967 Jul; 12(7):609-19. PubMed ID: 4299328
    [No Abstract]   [Full Text] [Related]  

  • 43. Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma.
    Gebbia V; Boussen H; Valerio MR
    Anticancer Res; 2012 Feb; 32(2):529-36. PubMed ID: 22287742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
    Kovach JS; Moertel CG; Schutt AJ; Reitemeier RG; Hahn RG
    Cancer Chemother Rep; 1973; 57(3):357-9. PubMed ID: 4584486
    [No Abstract]   [Full Text] [Related]  

  • 45. Short-term sequential therapy with vinblastine (NSC-49842) and cyclophosphamide (NSC-26271) in Hodgkin's disease.
    DeConti RC; Mitchell MS; Marsh JC; Bertino JR
    Cancer Chemother Rep; 1971 Dec; 55(5):607-10. PubMed ID: 4946083
    [No Abstract]   [Full Text] [Related]  

  • 46. Advances in the multimodal primary management of cancer.
    DeVita VT; Henney JE; Weiss RB
    Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination chemotherapy as an adjuvant treatment in operable breast cancer.
    Bonadonna G; Brusamolino E; Valagussa P; Rossi A; Brugnatelli L; Brambilla C; De Lena M; Tancini G; Bajetta E; Musumeci R; Veronesi U
    N Engl J Med; 1976 Feb; 294(8):405-10. PubMed ID: 1246307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Experience with emetine hydrochloride (NSC 33669) as an antitumor agent.
    Panettiere F; Coltman CA
    Cancer; 1971 Apr; 27(4):835-41. PubMed ID: 4929936
    [No Abstract]   [Full Text] [Related]  

  • 49. Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation.
    Muggia FM; Perloff M; Chia GA; Reed LJ; Escher GC
    Cancer Chemother Rep; 1974; 58(6):919-26. PubMed ID: 4614899
    [No Abstract]   [Full Text] [Related]  

  • 50. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH; Potish RA
    Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ
    Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
    [No Abstract]   [Full Text] [Related]  

  • 52. Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer.
    Hryniuk WM; Figueredo A; Goodyear M
    Semin Oncol; 1987 Dec; 14(4 Suppl 4):3-11. PubMed ID: 3317849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moderately high-dosage methotrexate medication in metastatic breast cancer.
    Wils JA
    Neth J Med; 1980; 23(2):59-61. PubMed ID: 7374869
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF; Eagan RT; Edmonson JH
    Cancer Chemother Rep; 1975; 59(2 Pt 1):451-3. PubMed ID: 1097102
    [No Abstract]   [Full Text] [Related]  

  • 55. [Joint radiation and chemotherapy of squamous cell lung cancer].
    Abisatov KhA
    Med Radiol (Mosk); 1979 May; 24(5):3-10. PubMed ID: 374921
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 57. Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Bodey GP; Rodriguez V; Hart J; Freireich EJ
    Cancer Chemother Rep; 1970 Aug; 54(4):255-62. PubMed ID: 4946010
    [No Abstract]   [Full Text] [Related]  

  • 58. Sequential 5-fluorouracil, methotrexate, and calcium leucovorin in metastatic colorectal cancer.
    Hansen RM; Banerjee TK; Davis HL; Zaentz SD; Schiferl EA; Ousley JL; Pogodzinski AE; Trump DL
    Wis Med J; 1988 May; 87(5):20-3. PubMed ID: 3291405
    [No Abstract]   [Full Text] [Related]  

  • 59. Combination chemotherapy in disseminated carcinoma of the breast.
    Kaufman S; Goldstein M
    Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
    [No Abstract]   [Full Text] [Related]  

  • 60. Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040).
    Bitran J; Golomb HM; Desser RK; Colman M
    Cancer Treat Rep; 1976 Mar; 60(3):221-3. PubMed ID: 177208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.